Reviews Anti-Inhibitor Coagulant Complex, Heat Treated


No reviews yet.

Autoplex-T Drug Description
Autoplex® T
Anti-Inhibitor Coagulant Complex Heat Treated

Caution: This product is to be used only in patients with inhibitors to
Factor VIII.
Warning: This is a potent drug with potential hazards. For maximal safety
and efficacy, carefully read and follow directions below.

DRUG DESCRIPTION



What are the possible side effects of anti-inhibitor coagulant complex (Autoplex T, Feiba VH)?

Anti-inhibitor coagulant complex is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although anti-inhibitor coagulant complex is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using anti-inhibitor coagulant complex.
Some viruses, such as parovovirus B19 and hepatitis A,...
Read All Potential Side Effects for Autoplex-T »




Autoplex® T*, Anti-Inhibitor Coagulant Complex, Heat Treated, is a sterile
product prepared from pooled human plasma with subsequent alcohol fractionation
to Cohn Fraction IV1. It contains, in concentrated form, variable
amounts of activated and precursor vitamin K-dependent clotting factors. Factors
of the kinin generating system are also present. The product is standardized
by its ability to correct the clotting time of Factor VIII deficient plasma
or Factor VIII deficient plasma which contains inhibitors to Factor VIII.
When reconstituted, this product contains a maximum of 2 units per mL of heparin and a residual amount of polyethylene glycol (2 mg per mL, maximum). It also contains 0.02 M sodium citrate and the sodium content is 177 ± 15 milliequivalents per liter.
Laboratory testing of several lots of Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated, has shown the presence of Factor VIII coagulant antigen (VIII:CAg). Although anamnestic response to this antigen following administration of the product was not observed during the clinical trials, the possibility of such a response does exist.
Each lot of Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated,
is assayed and labeled for units of Hyland Factor VIII correctional activity.
Factor VIII correctional activity may not be exclusively related to the efficacious
component(s). (See CLINICAL PHARMACOLOGY.)
During the manufacturing process, this product was heated for 6 days at 60°C. This heating step is designed to reduce the risk of transmission of hepatitis and other viral diseases. However, no procedure has been shown to be totally effective in removing hepatitis infectivity from Anti-Inhibitor Coagulant Complex.
Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated, must
be administered intravenously.
*This product and/or its manufacture covered by U.S. Patent Nos. 4,286,056,
4,287,180, 4,357,321, 4,382,083, 4,459,288, and 4,495,278. The “T” indicates
that the product is heat treated.Last reviewed on RxList: 1/13/2009




Autoplex-T Drug Description
Autoplex® T
Anti-Inhibitor Coagulant Complex Heat Treated

Caution: This product is to be used only in patients with inhibitors to
Factor VIII.
Warning: This is a potent drug with potential hazards. For maximal safety
and efficacy, carefully read and follow directions below.

DRUG DESCRIPTION



What are the possible side effects of anti-inhibitor coagulant complex (Autoplex T, Feiba VH)?

Anti-inhibitor coagulant complex is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although anti-inhibitor coagulant complex is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using anti-inhibitor coagulant complex.
Some viruses, such as parovovirus B19 and hepatitis A,...
Read All Potential Side Effects for Autoplex-T »




Autoplex® T*, Anti-Inhibitor Coagulant Complex, Heat Treated, is a sterile
product prepared from pooled human plasma with subsequent alcohol fractionation
to Cohn Fraction IV1. It contains, in concentrated form, variable
amounts of activated and precursor vitamin K-dependent clotting factors. Factors
of the kinin generating system are also present. The product is standardized
by its ability to correct the clotting time of Factor VIII deficient plasma
or Factor VIII deficient plasma which contains inhibitors to Factor VIII.
When reconstituted, this product contains a maximum of 2 units per mL of heparin and a residual amount of polyethylene glycol (2 mg per mL, maximum). It also contains 0.02 M sodium citrate and the sodium content is 177 ± 15 milliequivalents per liter.
Laboratory testing of several lots of Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated, has shown the presence of Factor VIII coagulant antigen (VIII:CAg). Although anamnestic response to this antigen following administration of the product was not observed during the clinical trials, the possibility of such a response does exist.
Each lot of Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated,
is assayed and labeled for units of Hyland Factor VIII correctional activity.
Factor VIII correctional activity may not be exclusively related to the efficacious
component(s). (See CLINICAL PHARMACOLOGY.)
During the manufacturing process, this product was heated for 6 days at 60°C. This heating step is designed to reduce the risk of transmission of hepatitis and other viral diseases. However, no procedure has been shown to be totally effective in removing hepatitis infectivity from Anti-Inhibitor Coagulant Complex.
Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated, must
be administered intravenously.
*This product and/or its manufacture covered by U.S. Patent Nos. 4,286,056,
4,287,180, 4,357,321, 4,382,083, 4,459,288, and 4,495,278. The “T” indicates
that the product is heat treated.Last reviewed on RxList: 1/13/2009




Autoplex-T Drug Description
Autoplex® T
Anti-Inhibitor Coagulant Complex Heat Treated

Caution: This product is to be used only in patients with inhibitors to
Factor VIII.
Warning: This is a potent drug with potential hazards. For maximal safety
and efficacy, carefully read and follow directions below.

DRUG DESCRIPTION



What are the possible side effects of anti-inhibitor coagulant complex (Autoplex T, Feiba VH)?

Anti-inhibitor coagulant complex is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although anti-inhibitor coagulant complex is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using anti-inhibitor coagulant complex.
Some viruses, such as parovovirus B19 and hepatitis A,...
Read All Potential Side Effects for Autoplex-T »




Autoplex® T*, Anti-Inhibitor Coagulant Complex, Heat Treated, is a sterile
product prepared from pooled human plasma with subsequent alcohol fractionation
to Cohn Fraction IV1. It contains, in concentrated form, variable
amounts of activated and precursor vitamin K-dependent clotting factors. Factors
of the kinin generating system are also present. The product is standardized
by its ability to correct the clotting time of Factor VIII deficient plasma
or Factor VIII deficient plasma which contains inhibitors to Factor VIII.
When reconstituted, this product contains a maximum of 2 units per mL of heparin and a residual amount of polyethylene glycol (2 mg per mL, maximum). It also contains 0.02 M sodium citrate and the sodium content is 177 ± 15 milliequivalents per liter.
Laboratory testing of several lots of Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated, has shown the presence of Factor VIII coagulant antigen (VIII:CAg). Although anamnestic response to this antigen following administration of the product was not observed during the clinical trials, the possibility of such a response does exist.
Each lot of Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated,
is assayed and labeled for units of Hyland Factor VIII correctional activity.
Factor VIII correctional activity may not be exclusively related to the efficacious
component(s). (See CLINICAL PHARMACOLOGY.)
During the manufacturing process, this product was heated for 6 days at 60°C. This heating step is designed to reduce the risk of transmission of hepatitis and other viral diseases. However, no procedure has been shown to be totally effective in removing hepatitis infectivity from Anti-Inhibitor Coagulant Complex.
Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated, must
be administered intravenously.
*This product and/or its manufacture covered by U.S. Patent Nos. 4,286,056,
4,287,180, 4,357,321, 4,382,083, 4,459,288, and 4,495,278. The “T” indicates
that the product is heat treated.Last reviewed on RxList: 1/13/2009




Autoplex-T Drug Description
Autoplex® T
Anti-Inhibitor Coagulant Complex Heat Treated

Caution: This product is to be used only in patients with inhibitors to
Factor VIII.
Warning: This is a potent drug with potential hazards. For maximal safety
and efficacy, carefully read and follow directions below.

DRUG DESCRIPTION



What are the possible side effects of anti-inhibitor coagulant complex (Autoplex T, Feiba VH)?

Anti-inhibitor coagulant complex is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although anti-inhibitor coagulant complex is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using anti-inhibitor coagulant complex.
Some viruses, such as parovovirus B19 and hepatitis A,...
Read All Potential Side Effects for Autoplex-T »




Autoplex® T*, Anti-Inhibitor Coagulant Complex, Heat Treated, is a sterile
product prepared from pooled human plasma with subsequent alcohol fractionation
to Cohn Fraction IV1. It contains, in concentrated form, variable
amounts of activated and precursor vitamin K-dependent clotting factors. Factors
of the kinin generating system are also present. The product is standardized
by its ability to correct the clotting time of Factor VIII deficient plasma
or Factor VIII deficient plasma which contains inhibitors to Factor VIII.
When reconstituted, this product contains a maximum of 2 units per mL of heparin and a residual amount of polyethylene glycol (2 mg per mL, maximum). It also contains 0.02 M sodium citrate and the sodium content is 177 ± 15 milliequivalents per liter.
Laboratory testing of several lots of Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated, has shown the presence of Factor VIII coagulant antigen (VIII:CAg). Although anamnestic response to this antigen following administration of the product was not observed during the clinical trials, the possibility of such a response does exist.
Each lot of Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated,
is assayed and labeled for units of Hyland Factor VIII correctional activity.
Factor VIII correctional activity may not be exclusively related to the efficacious
component(s). (See CLINICAL PHARMACOLOGY.)
During the manufacturing process, this product was heated for 6 days at 60°C. This heating step is designed to reduce the risk of transmission of hepatitis and other viral diseases. However, no procedure has been shown to be totally effective in removing hepatitis infectivity from Anti-Inhibitor Coagulant Complex.
Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated, must
be administered intravenously.
*This product and/or its manufacture covered by U.S. Patent Nos. 4,286,056,
4,287,180, 4,357,321, 4,382,083, 4,459,288, and 4,495,278. The “T” indicates
that the product is heat treated.Last reviewed on RxList: 1/13/2009




Autoplex-T Drug Description
Autoplex® T
Anti-Inhibitor Coagulant Complex Heat Treated

Caution: This product is to be used only in patients with inhibitors to
Factor VIII.
Warning: This is a potent drug with potential hazards. For maximal safety
and efficacy, carefully read and follow directions below.

DRUG DESCRIPTION



What are the possible side effects of anti-inhibitor coagulant complex (Autoplex T, Feiba VH)?

Anti-inhibitor coagulant complex is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although anti-inhibitor coagulant complex is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using anti-inhibitor coagulant complex.
Some viruses, such as parovovirus B19 and hepatitis A,...
Read All Potential Side Effects for Autoplex-T »




Autoplex® T*, Anti-Inhibitor Coagulant Complex, Heat Treated, is a sterile
product prepared from pooled human plasma with subsequent alcohol fractionation
to Cohn Fraction IV1. It contains, in concentrated form, variable
amounts of activated and precursor vitamin K-dependent clotting factors. Factors
of the kinin generating system are also present. The product is standardized
by its ability to correct the clotting time of Factor VIII deficient plasma
or Factor VIII deficient plasma which contains inhibitors to Factor VIII.
When reconstituted, this product contains a maximum of 2 units per mL of heparin and a residual amount of polyethylene glycol (2 mg per mL, maximum). It also contains 0.02 M sodium citrate and the sodium content is 177 ± 15 milliequivalents per liter.
Laboratory testing of several lots of Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated, has shown the presence of Factor VIII coagulant antigen (VIII:CAg). Although anamnestic response to this antigen following administration of the product was not observed during the clinical trials, the possibility of such a response does exist.
Each lot of Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated,
is assayed and labeled for units of Hyland Factor VIII correctional activity.
Factor VIII correctional activity may not be exclusively related to the efficacious
component(s). (See CLINICAL PHARMACOLOGY.)
During the manufacturing process, this product was heated for 6 days at 60°C. This heating step is designed to reduce the risk of transmission of hepatitis and other viral diseases. However, no procedure has been shown to be totally effective in removing hepatitis infectivity from Anti-Inhibitor Coagulant Complex.
Autoplex® T, Anti-Inhibitor Coagulant Complex, Heat Treated, must
be administered intravenously.
*This product and/or its manufacture covered by U.S. Patent Nos. 4,286,056,
4,287,180, 4,357,321, 4,382,083, 4,459,288, and 4,495,278. The “T” indicates
that the product is heat treated.Last reviewed on RxList: 1/13/2009





Other reviews about Anti-Inhibitor Coagulant Complex, Heat Treated on web:

Learn about the prescription medication Autoplex-T (Anti-Inhibitor Coagulant Complex, Heat Treated), drug uses, dosage, side effects, drug interactions, warnings, reviews and ... Autoplex-T (Anti-Inhibitor Coagulant Complex, Heat Treated) Drug ...


Anti Inhibitor Coagulant Complex Heat Treated Side Effects. Lifestyle, fitness & health information about Anti Inhibitor Coagulant Complex Heat Treated Side Effects. Anti Inhibitor Coagulant Complex Heat Treated Side Effects ...


Caution: This product is to be used only in patients with inhibitors to Factor VIII. Anti-Inhibitor Coagulant Complex Heat Treated Autoplex®T


Learn about Autoplex-T (Anti-Inhibitor Coagulant Complex, Heat Treated) - Side Effects, Drug Interactions, Pictures, Patient Information on RxList Autoplex-T (Anti-Inhibitor Coagulant Complex, Heat Treated ...


Anti-Inhibitor Coagulant Complex, Heat Treated. MEDgle is a medical and health search allowing you search your symptoms, diagnoses, drugs, procedures, and more. . estilo de vida: Anti-Inhibitor Coagulant Complex, Heat Treated ...


A clinical study 4 testing Antihemophilic Factor treated by a similar vapor heating procedure ... WARNINGS Anti-Inhibitor Coagulant Complex, Feiba VH, Vapor Heated must be used only in ... BAXTER Anti-Inhibitor Coagulant Complex Feiba VH Vapor Heated ...


A clinical study 4 testing Antihemophilic Factor treated by a similar vapor heating ... showed that, based on subjective patient evaluation, Anti-Inhibitor Coagulant Complex was ... anti-inhibitor coagulant complex vapor heated (Feiba VH)


Anti-inhibitor coagulant complex (AICC) is a sterile, dried concentrate prepared from pooled human Source Plasma and/or Plasma {03} {04} {05}. The product is heat-treated as a method ... Autoplex T Drug Information, Professional


Although anti-inhibitor coagulant complex is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. anti-inhibitor coagulant complex (injectable) - Health.com


A clinical study 4 testing Antihemophilic Factor treated by a similar vapor heating procedure ... WARNINGS FEIBA VH, Anti-Inhibitor Coagulant Complex, Vapor Heated, is made from human ... FEIBA VH Anti-Inhibitor Coagulant Complex Vapor Heated





Featured Reviews

Reviews Sulfacetamide and Prednisolone

Vasocidin Drug Description VASOCIDIN (prednisolone sodium phosphate and sulfacetamide sodium) Solution DRUG DESCRIPTION VASOCIDIN is a sterile topical ophthalmic solution combining an anti-infective and an adrenocortical steroid having...
Read More  |  Review This
Reviews Fentanyl Transdermal

Duragesic Drug Description DURAGESIC® (fentanyl transdermal system) FOR USE IN OPIOID-TOLERANT PATIENTS ONLY DURAGESIC® contains a high concentration of a potent Schedule II opioid agonist, fentanyl. Schedule II opioid substances...
Read More  |  Review This
Reviews Gentamican Sulfate Ophthalmic Ointment

Gentak Drug Description GENTAK® (gentamicin sulfate) Ophthalmic Ointment USP, 0.3% Sterile DRUG DESCRIPTION What are the possible side effects of gentamicin ophthalmic (Garamycin Ophthalmic, Gentak, Gentasol, Ocu-Mycin)? Serious...
Read More  |  Review This
Reviews Nortriptyline Hydrochloride Capsules

Nortriptyline Hydrochloride Drug Description Nortriptyline Hydrochloride (nortriptyline hydrochloride) Capsules Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking ...
Read More  |  Review This
Reviews Coly-Mycin S Otic

Coly-Mycin S Otic Drug Description Coly-Mycin® S Otic with Neomycin and Hydrocortisone (colistin sulfate—neomycin sulfate—thonzonium bromide—hydrocortisone acetate) Otic Suspension DRUG DESCRIPTION What are the possible side...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....